A Phase I, Randomized, Single-Dose Study to Evaluate the Biosimilarity of QL1206 to Denosumab Among Chinese Healthy Subjects

OBJECTIVE: This study was conducted to explore the tolerance, variability, pharmacokinetics (PK), and pharmacodynamics (PD) of denosumab biosimilar (QL1206) in healthy Chinese subjects. METHODS: This is a randomized, double-blind, two-arm, parallel study performed to examine the bioequivalence of de...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Pharmacol
Hlavní autoři: Zhang, Hong, Wu, Min, Zhu, Xiaoxue, Li, Cuiyun, Li, Xiaojiao, Sun, Jixuan, Liu, Chengjiao, Liu, Quan, Wei, Wei, Niu, Junqi, Ding, Yanhua
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2020
Témata:
Pharmacology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7580200/
https://ncbi.nlm.nih.gov/pubmed/33132906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.01329
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky